CLINICAL ROLE -
Combination Treatment with Daclatasvir Produces Good Results in Patients with Genotype 4 Hepatitis C
SVR12 rates significantly higher in patients treated with daclatasvir/peginterferon alfa/ribavirin combination.
Read More